Skip to content
Lower risk Drug recall · FDA · Published December 12, 2023

GlaxoSmithKline ANORO ELLIPTA inhaler recall: Failed release testing

GlaxoSmithKline recalls ANORO ELLIPTA inhalers with failed release testing for coarse particle mass. This may affect inhaler safety and requires checking the NDC code and lot number.

🇺🇸 FDA recall #D-0160-2024DrugGlaxoSmithKline ›
Take action

Contact the company

Recalling firmGlaxoSmithKline LLC410 Blackwell St · Durham, NC 27701-3986
✎ GovInfoNow plain-language explainer

What happened, in plain English

GlaxoSmithKline is recalling ANORO ELLIPTA inhalers that failed quality testing. This could mean the inhaler doesn't work properly and might not deliver medication safely. Read more at govinfonow.com/recall/32926-glaxosmithkline-anoro-ellipta-inhaler-recall-failed-release-testing.

Source Summary by GovInfoNow · govinfonow.com/recall/32926-glaxosmithkline-anoro-ellipta-inhaler-recall-failed-release-testing · Updated August 17, 2026 · FDA enforcement record: FDA #D-0160-2024

Cite this page

“GlaxoSmithKline ANORO ELLIPTA inhaler recall: Failed release testing.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32926-glaxosmithkline-anoro-ellipta-inhaler-recall-failed-release-testing. Based on FDA recall #D-0160-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0160-2024%22&limit=1).

Why it’s dangerous

The inhaler failed quality testing for coarse particle mass. This means the medication might not be delivered properly to the lungs, potentially reducing effectiveness.

Who’s affected

People with asthma or COPD who use ANORO ELLIPTA inhalers. Those with the specific NDC code 0173-0869-10 and lot number 7Y9S are most at risk.

How to tell if you have this one

Check for the NDC code 0173-0869-10 and lot number 7Y9S on the inhaler packaging. The product is a prescription inhaler with 30 doses per unit.

  • Brand
    GlaxoSmithKline
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC code 0173-0869-10 and lot number 7Y9S on the inhaler packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Distributed Nationwide in the USA and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Dec 12, 202312. FDA classified it Class III: Dec 22, 202323. Published in FDA’s Enforcement Report: Jan 3, 202434. FDA terminated the recall: Sep 12, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0160-2024 (December 12, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0160-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA